Erschienen in:
01.12.2015 | Research Article
Histone deacetylase 6 promotes growth of glioblastoma through inhibition of SMAD2 signaling
verfasst von:
Shun Li, Xiao Liu, Xiangrong Chen, Liu Zhang, Xiangyu Wang
Erschienen in:
Tumor Biology
|
Ausgabe 12/2015
Einloggen, um Zugang zu erhalten
Abstract
Histone deacetylases (HDACs) play a role in the tumorigenesis of glioblastoma multiforme (GBM), whereas the underlying mechanism has not been elucidated. Here, we reported significantly higher HDAC6 levels in GBM from the patients. GBM cell growth was significantly inhibited by ACY-1215, a specific HDAC6 inhibitor. Further analyses show that HDAC6 may promote growth of GBM cells through inhibition of SMAD2 phosphorylation to downregulate p21. Thus, our data demonstrate a previously unrecognized regulation pathway in that HDAC6 increases GBM growth through attenuating transforming growth factor β (TGFβ) receptor signaling.